643 related articles for article (PubMed ID: 10416597)
1. Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation.
Gorski DH; Beckett MA; Jaskowiak NT; Calvin DP; Mauceri HJ; Salloum RM; Seetharam S; Koons A; Hari DM; Kufe DW; Weichselbaum RR
Cancer Res; 1999 Jul; 59(14):3374-8. PubMed ID: 10416597
[TBL] [Abstract][Full Text] [Related]
2. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels.
Larcher F; Robles AI; Duran H; Murillas R; Quintanilla M; Cano A; Conti CJ; Jorcano JL
Cancer Res; 1996 Dec; 56(23):5391-6. PubMed ID: 8968091
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of tumor growth and metastasis by an immunoneutralizing monoclonal antibody to human vascular endothelial growth factor/vascular permeability factor121.
Asano M; Yukita A; Matsumoto T; Kondo S; Suzuki H
Cancer Res; 1995 Nov; 55(22):5296-301. PubMed ID: 7585591
[TBL] [Abstract][Full Text] [Related]
4. Significance of vascular endothelial growth factor/vascular permeability factor for solid tumor growth, and its inhibition by the antibody.
Kondo S; Asano M; Suzuki H
Biochem Biophys Res Commun; 1993 Aug; 194(3):1234-41. PubMed ID: 7688963
[TBL] [Abstract][Full Text] [Related]
5. Potentiation of the antiangiogenic ability of linomide by androgen ablation involves down-regulation of vascular endothelial growth factor in human androgen-responsive prostatic cancers.
Joseph IB; Isaacs JT
Cancer Res; 1997 Mar; 57(6):1054-7. PubMed ID: 9067270
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor promotes tumor dissemination by a mechanism distinct from its effect on primary tumor growth.
Melnyk O; Shuman MA; Kim KJ
Cancer Res; 1996 Feb; 56(4):921-4. PubMed ID: 8631034
[TBL] [Abstract][Full Text] [Related]
7. The vascular endothelial growth factor proteins: identification of biologically relevant regions by neutralizing monoclonal antibodies.
Kim KJ; Li B; Houck K; Winer J; Ferrara N
Growth Factors; 1992; 7(1):53-64. PubMed ID: 1380254
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor regulates angiogenesis and vascular permeability in Kaposi's sarcoma.
Cornali E; Zietz C; Benelli R; Weninger W; Masiello L; Breier G; Tschachler E; Albini A; Stürzl M
Am J Pathol; 1996 Dec; 149(6):1851-69. PubMed ID: 8952523
[TBL] [Abstract][Full Text] [Related]
9. Complete inhibition of angiogenesis and growth of microtumors by anti-vascular endothelial growth factor neutralizing antibody: novel concepts of angiostatic therapy from intravital videomicroscopy.
Borgström P; Hillan KJ; Sriramarao P; Ferrara N
Cancer Res; 1996 Sep; 56(17):4032-9. PubMed ID: 8752175
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the tumor vasculature and metastatic behavior of xenografts of human melanoma cell lines transfected with vascular permeability factor.
Pötgens AJ; van Altena MC; Lubsen NH; Ruiter DJ; de Waal RM
Am J Pathol; 1996 Apr; 148(4):1203-17. PubMed ID: 8644861
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor is essential for initial but not continued in vivo growth of human breast carcinoma cells.
Yoshiji H; Harris SR; Thorgeirsson UP
Cancer Res; 1997 Sep; 57(18):3924-8. PubMed ID: 9307273
[TBL] [Abstract][Full Text] [Related]
12. Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors.
Petit AM; Rak J; Hung MC; Rockwell P; Goldstein N; Fendly B; Kerbel RS
Am J Pathol; 1997 Dec; 151(6):1523-30. PubMed ID: 9403702
[TBL] [Abstract][Full Text] [Related]
13. Neovasculature induced by vascular endothelial growth factor is fenestrated.
Roberts WG; Palade GE
Cancer Res; 1997 Feb; 57(4):765-72. PubMed ID: 9044858
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor confers a growth advantage in vitro and in vivo to stromal cells cultured from neonatal hemangiomas.
Berard M; Sordello S; Ortega N; Carrier JL; Peyri N; Wassef M; Bertrand N; Enjolras O; Drouet L; Plouet J
Am J Pathol; 1997 Apr; 150(4):1315-26. PubMed ID: 9094988
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis.
Shweiki D; Itin A; Soffer D; Keshet E
Nature; 1992 Oct; 359(6398):843-5. PubMed ID: 1279431
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of angiogenesis in human glioblastomas by chromosome 10 induction of thrombospondin-1.
Hsu SC; Volpert OV; Steck PA; Mikkelsen T; Polverini PJ; Rao S; Chou P; Bouck NP
Cancer Res; 1996 Dec; 56(24):5684-91. PubMed ID: 8971176
[TBL] [Abstract][Full Text] [Related]
17. Development and malignant progression of astrocytomas in GFAP-v-src transgenic mice.
Weissenberger J; Steinbach JP; Malin G; Spada S; Rülicke T; Aguzzi A
Oncogene; 1997 May; 14(17):2005-13. PubMed ID: 9160879
[TBL] [Abstract][Full Text] [Related]
18. Tumor-secreted vascular permeability factor/vascular endothelial growth factor influences photosensitizer uptake.
Roberts WG; Hasan T
Cancer Res; 1993 Jan; 53(1):153-7. PubMed ID: 8416739
[TBL] [Abstract][Full Text] [Related]
19. Vascular permeability factor expression influences tumor angiogenesis in human melanoma lines xenografted to nude mice.
Pötgens AJ; Lubsen NH; van Altena MC; Schoenmakers JG; Ruiter DJ; de Waal RM
Am J Pathol; 1995 Jan; 146(1):197-209. PubMed ID: 7531947
[TBL] [Abstract][Full Text] [Related]
20. FCE 27266, a sulfonic distamycin derivative, inhibits experimental and spontaneous lung and liver metastasis.
Sola F; Farao M; Ciomei M; Pastori A; Mongelli N; Grandi M
Invasion Metastasis; 1995; 15(5-6):222-31. PubMed ID: 8765197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
